4//SEC Filing
Kraus Carl N 4
Accession 0001214659-25-015047
CIK 0001398733other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 2:01 PM ET
Size
5.3 KB
Accession
0001214659-25-015047
Insider Transaction Report
Form 4
Kraus Carl N
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-10-15$7.00/sh−20,272$141,904→ 282,475 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.
- [F2]The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001946475
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 2:01 PM ET
- Size
- 5.3 KB